These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
868 related articles for article (PubMed ID: 11555594)
1. The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas. Calogero A; Arcella A; De Gregorio G; Porcellini A; Mercola D; Liu C; Lombari V; Zani M; Giannini G; Gagliardi FM; Caruso R; Gulino A; Frati L; Ragona G Clin Cancer Res; 2001 Sep; 7(9):2788-96. PubMed ID: 11555594 [TBL] [Abstract][Full Text] [Related]
2. Deregulation of the TP53/p14ARF tumor suppressor pathway in low-grade diffuse astrocytomas and its influence on clinical course. Watanabe T; Katayama Y; Yoshino A; Komine C; Yokoyama T Clin Cancer Res; 2003 Oct; 9(13):4884-90. PubMed ID: 14581362 [TBL] [Abstract][Full Text] [Related]
3. p53 gene mutation and ink4a-arf deletion appear to be two mutually exclusive events in human glioblastoma. Fulci G; Labuhn M; Maier D; Lachat Y; Hausmann O; Hegi ME; Janzer RC; Merlo A; Van Meir EG Oncogene; 2000 Aug; 19(33):3816-22. PubMed ID: 10949938 [TBL] [Abstract][Full Text] [Related]
4. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas. Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835 [TBL] [Abstract][Full Text] [Related]
5. P16(INK4A) is implicated in both the immediate and adaptative response of human keratinocytes to UVB irradiation. Chazal M; Marionnet C; Michel L; Mollier K; Dazard JE; Della Valle V; Larsen CJ; Gras MP; Basset-Séguin N Oncogene; 2002 Apr; 21(17):2652-61. PubMed ID: 11965538 [TBL] [Abstract][Full Text] [Related]
6. Alterations of the INK4a-ARF gene locus in pleomorphic adenoma of the parotid gland. Weber A; Langhanki L; Schütz A; Wittekind C; Bootz F; Tannapfel A J Pathol; 2002 Nov; 198(3):326-34. PubMed ID: 12375265 [TBL] [Abstract][Full Text] [Related]
7. Investigation of germline PTEN, p53, p16(INK4A)/p14(ARF), and CDK4 alterations in familial glioma. Tachibana I; Smith JS; Sato K; Hosek SM; Kimmel DW; Jenkins RB Am J Med Genet; 2000 May; 92(2):136-41. PubMed ID: 10797439 [TBL] [Abstract][Full Text] [Related]
8. CDK4 and MDM2 gene alterations mainly occur in highly proliferative and aggressive mantle cell lymphomas with wild-type INK4a/ARF locus. Hernández L; Beà S; Pinyol M; Ott G; Katzenberger T; Rosenwald A; Bosch F; López-Guillermo A; Delabie J; Colomer D; Montserrat E; Campo E Cancer Res; 2005 Mar; 65(6):2199-206. PubMed ID: 15781632 [TBL] [Abstract][Full Text] [Related]
9. Profiles of the 2 INK4a gene products, p16 and p14ARF, in human reference urothelium and bladder carcinomas, according to pRb and p53 protein status. Le Frère-Belda MA; Gil Diez de Medina S; Daher A; Martin N; Albaud B; Heudes D; Abbou CC; Thiery JP; Zafrani ES; Radvanyi F; Chopin D Hum Pathol; 2004 Jul; 35(7):817-24. PubMed ID: 15257544 [TBL] [Abstract][Full Text] [Related]
10. p16/p14(ARF) cell cycle regulatory pathways in primary neuroblastoma: p16 expression is associated with advanced stage disease. Omura-Minamisawa M; Diccianni MB; Chang RC; Batova A; Bridgeman LJ; Schiff J; Cohn SL; London WB; Yu AL Clin Cancer Res; 2001 Nov; 7(11):3481-90. PubMed ID: 11705866 [TBL] [Abstract][Full Text] [Related]
11. INK4a/ARF locus alterations in human non-Hodgkin's lymphomas mainly occur in tumors with wild-type p53 gene. Pinyol M; Hernández L; Martínez A; Cobo F; Hernández S; Beà S; López-Guillermo A; Nayach I; Palacín A; Nadal A; Fernández PL; Montserrat E; Cardesa A; Campo E Am J Pathol; 2000 Jun; 156(6):1987-96. PubMed ID: 10854221 [TBL] [Abstract][Full Text] [Related]
12. Deregulation of the p14ARF/MDM2/p53 pathway is a prerequisite for human astrocytic gliomas with G1-S transition control gene abnormalities. Ichimura K; Bolin MB; Goike HM; Schmidt EE; Moshref A; Collins VP Cancer Res; 2000 Jan; 60(2):417-24. PubMed ID: 10667596 [TBL] [Abstract][Full Text] [Related]
13. Quantitative real-time PCR does not show selective targeting of p14(ARF) but concomitant inactivation of both p16(INK4A) and p14(ARF) in 105 human primary gliomas. Labuhn M; Jones G; Speel EJ; Maier D; Zweifel C; Gratzl O; Van Meir EG; Hegi ME; Merlo A Oncogene; 2001 Mar; 20(9):1103-9. PubMed ID: 11314047 [TBL] [Abstract][Full Text] [Related]
14. Ionizing radiation down-regulates p53 protein in primary Egr-1-/- mouse embryonic fibroblast cells causing enhanced resistance to apoptosis. Das A; Chendil D; Dey S; Mohiuddin M; Mohiuddin M; Milbrandt J; Rangnekar VM; Ahmed MM J Biol Chem; 2001 Feb; 276(5):3279-86. PubMed ID: 11035041 [TBL] [Abstract][Full Text] [Related]
15. Mdm2 overexpression and p14(ARF) inactivation are two mutually exclusive events in primary human lung tumors. Eymin B; Gazzeri S; Brambilla C; Brambilla E Oncogene; 2002 Apr; 21(17):2750-61. PubMed ID: 11965548 [TBL] [Abstract][Full Text] [Related]
16. Deregulation of the p14ARF/Mdm2/p53 pathway and G1/S transition in two glioblastoma sets. Ghimenti C; Fiano V; Chiadò-Piat L; Chiò A; Cavalla P; Schiffer D J Neurooncol; 2003 Jan; 61(2):95-102. PubMed ID: 12622447 [TBL] [Abstract][Full Text] [Related]
17. Inactivation of the ARF-MDM-2-p53 pathway in sporadic Burkitt's lymphoma in children. Wilda M; Bruch J; Harder L; Rawer D; Reiter A; Borkhardt A; Woessmann W Leukemia; 2004 Mar; 18(3):584-8. PubMed ID: 14712292 [TBL] [Abstract][Full Text] [Related]
18. INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck. Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A Virchows Arch; 2002 Aug; 441(2):133-42. PubMed ID: 12189502 [TBL] [Abstract][Full Text] [Related]
19. Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma. Edmunds SC; Kelsell DP; Hungerford JL; Cree IA Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2845-51. PubMed ID: 12202501 [TBL] [Abstract][Full Text] [Related]
20. Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer. Sanchez-Cespedes M; Reed AL; Buta M; Wu L; Westra WH; Herman JG; Yang SC; Jen J; Sidransky D Oncogene; 1999 Oct; 18(43):5843-9. PubMed ID: 10557071 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]